The HCV NS5B Nucleoside and Non-Nucleoside Inhibitors

被引：47
作者：
Membreno, Fernando E. [1 ]
Lawitz, Eric J. [1 ]
机构：
[1] Alamo Med Res, San Antonio, TX 78215 USA
来源：
CLINICS IN LIVER DISEASE | 2011年 / 15卷 / 03期
关键词：
Hepatitis C virus; NS5B nucleoside inhibitors; Non-nucleoside inhibitors; Polymerase inhibitors; HEPATITIS-C VIRUS; RNA-POLYMERASE INHIBITOR; ANTIVIRAL EFFICACY; HCVNS5B POLYMERASE; RESISTANCE; PROTEASE; INFECTION; PHARMACOKINETICS; PEGINTERFERON; TELAPREVIR;
D O I：
10.1016/j.cld.2011.05.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
This article introduces one of the most diverse classes of direct-acting antivirals for hepatitis C, the nucleoside and non-nucleoside NS5B polymerase inhibitors. Through a systematic review of the published literature, we describe their structure, mechanism of action, issues with resistance, and clinical effectiveness shown in the latest clinical trials. Direct-acting antiviral combination trials that have already shown some early promising results even in the setting of interferon-sparing antiviral regimens are discussed.
引用
收藏
页码：611 / +
页数：17
相关论文
共 56 条
[31]  
LAWITZ EJ, 2010, 61 ANN M AM ASS STUD, pA806
[32]   Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients [J].
Le Pogam, Sophie ;
Seshaadri, Amritha ;
Kosaka, Alan ;
Chiu, Sophie ;
Kang, Hyunsoon ;
Hu, Steven ;
Rajyaguru, Sonal ;
Symons, Julian ;
Cammack, Nick ;
Najera, Isabel .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (06) :1205-1216
[33]  
LEPOGAM S, 2010, 61 ANN M AM ASS STUD, P799
[34]  
Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937
[35]   Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors [J].
Ma, H ;
Leveque, V ;
De Witte, A ;
Li, WX ;
Hendricks, T ;
Clausen, SM ;
Cammack, N ;
Klumpp, K .
VIROLOGY, 2005, 332 (01) :8-15
[36]   Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection [J].
McHutchison, John G. ;
Everson, Gregory T. ;
Gordon, Stuart C. ;
Jacobson, Ira M. ;
Sulkowski, Mark ;
Kauffman, Robert ;
McNair, Lindsay ;
Alam, John ;
Muir, Andrew J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) :1827-1838
[37]   Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection [J].
McHutchison, John G. ;
Lawitz, Eric J. ;
Shiffman, Mitchell L. ;
Muir, Andrew J. ;
Galler, Greg W. ;
McCone, Jonathan ;
Nyberg, Lisa M. ;
Lee, William M. ;
Ghalib, Reem H. ;
Schiff, Eugene R. ;
Galati, Joseph S. ;
Bacon, Bruce R. ;
Davis, Mitchell N. ;
Mukhopadhyay, Pabak ;
Koury, Kenneth ;
Noviello, Stephanie ;
Pedicone, Lisa D. ;
Brass, Clifford A. ;
Albrecht, Janice K. ;
Sulkowski, Mark S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (06) :580-593
[38]   Darunavir A Review of its Use in the Management of HIV Infection in Adults [J].
McKeage, Kate ;
Perry, Caroline M. ;
Keam, Susan J. .
DRUGS, 2009, 69 (04) :477-503
[39]   HEPATITIS-C VIRUS SHARES AMINO-ACID-SEQUENCE SIMILARITY WITH PESTIVIRUSES AND FLAVIVIRUSES AS WELL AS MEMBERS OF 2 PLANT-VIRUS SUPERGROUPS [J].
MILLER, RH ;
PURCELL, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2057-2061
[40]  
Morquis M, 2008, HEPATOLOGY, V48, p1159A
123456